BioLife Solutions Files Definitive Proxy Statement
Ticker: BLFS · Form: DEFA14A · Filed: Jul 26, 2024 · CIK: 834365
| Field | Detail |
|---|---|
| Company | Biolife Solutions Inc (BLFS) |
| Form Type | DEFA14A |
| Filed Date | Jul 26, 2024 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 6 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, sec-filing, governance
TL;DR
BioLife Solutions dropped its proxy statement - shareholders vote soon on company matters.
AI Summary
BioLife Solutions, Inc. filed a Definitive Proxy Statement (DEFA14A) on July 26, 2024, detailing information for its upcoming shareholder meeting. The filing outlines the company's governance, executive compensation, and proposals to be voted on by shareholders. Specific details regarding the agenda, voting procedures, and any proposed amendments or elections are contained within the full document.
Why It Matters
This filing is crucial for shareholders as it provides the official information needed to understand and vote on key company decisions, impacting the future direction and governance of BioLife Solutions.
Risk Assessment
Risk Level: low — This is a standard regulatory filing (DEFA14A) for a public company's annual meeting, not indicating any immediate financial distress or unusual risk.
Key Players & Entities
- BIOLIFE SOLUTIONS, INC. (company) — Registrant
- 0001628280-24-033058 (filing_id) — Accession Number
- 20240726 (date) — Filing Date
- 3845 (industry_code) — Standard Industrial Classification
- DE (state) — State of Incorporation
- 1231 (date) — Fiscal Year End
- 3303 MONTE VILLA PARKWAY (address) — Business Address
- BOTHELL (city) — Business Address City
- WA (state) — Business Address State
- 98021 (zip_code) — Business Address Zip
FAQ
What type of filing is this DEFA14A for BioLife Solutions, Inc.?
This is a Definitive Proxy Statement filed by BioLife Solutions, Inc. on July 26, 2024, under Rule 14a-101 of the Securities Exchange Act of 1934.
What is the company's Central Index Key (CIK)?
BioLife Solutions, Inc.'s Central Index Key (CIK) is 0000834365.
Where is BioLife Solutions, Inc. headquartered?
BioLife Solutions, Inc. is headquartered in Bothell, Washington, with its business address at 3303 Monte Villa Parkway, Suite 310, Bothell, WA 98021.
When is BioLife Solutions, Inc.'s fiscal year end?
BioLife Solutions, Inc.'s fiscal year ends on December 31 (1231).
What is the Standard Industrial Classification (SIC) code for BioLife Solutions, Inc.?
The Standard Industrial Classification (SIC) code for BioLife Solutions, Inc. is 3845, which corresponds to Electromedical & Electrotherapeutic Apparatus.
Filing Stats: 1,613 words · 6 min read · ~5 pages · Grade level 13.8 · Accepted 2024-07-26 08:13:51
Filing Documents
- blfs-20240725.htm (DEFA14A) — 27KB
- blfs-20240725_g1.jpg (GRAPHIC) — 6KB
- blfs-20240725_g2.jpg (GRAPHIC) — 53KB
- blfs-20240725_g3.jpg (GRAPHIC) — 69KB
- blfs-20240725_g4.jpg (GRAPHIC) — 117KB
- blfs-20240725_g5.jpg (GRAPHIC) — 175KB
- blfs-20240725_g6.jpg (GRAPHIC) — 135KB
- blfs-20240725_g7.jpg (GRAPHIC) — 80KB
- blfs-20240725_g8.jpg (GRAPHIC) — 81KB
- blfs-20240725_g9.jpg (GRAPHIC) — 44KB
- 0001628280-24-033058.txt ( ) — 1989KB
- blfs-20240725.xsd (EX-101.SCH) — 2KB
- blfs-20240725_lab.xml (EX-101.LAB) — 6KB
- blfs-20240725_pre.xml (EX-101.PRE) — 3KB
- blfs-20240725_htm.xml (XML) — 1KB
Forward-Looking Statements
Forward-Looking Statements Certain statements contained in this Schedule 14A are not historical facts and may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "plans," "expects," "believes," "anticipates," "designed," and similar words are intended to identify forward-looking statements. Forward-looking statements are based on our current expectations and beliefs, and involve a number of risks and uncertainties that are difficult to predict and that could cause actual results to differ materially from those stated or implied by the forward-looking statements. A description of certain of these risks, uncertainties and other matters can be found in filings we make with the U.S. Securities and Exchange Commission (the "SEC"), all of which are available at www.sec.gov, including our Annual Report on Form 10-K as of and for the fiscal year ended December 31, 2023, filed with the SEC on February 29, 2024. Because forward-looking statements involve risks and uncertainties, actual results and events may differ materially from results and events currently expected by us. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. We undertake no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in its expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Additional Information and Where to Find It This filing is being made in connection with our 2024 Annual Meeting of Stockholders (the "Annual Meeting"). In connection with the Annual Meeting, we filed a definitive Proxy Statement (the "Proxy Statement") with the SEC on June 5, 2024. The Proxy Statement was mailed to our stockholders on or about June 5, 2024. We may also file other documents with the SEC regarding the Annual Meetin